Development of in vitro immunization in murine and human hybridoma technology
- 31 December 1987
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 5 (8) , 783-792
- https://doi.org/10.1016/0731-7085(87)80096-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Natural suppressor (NS) cells members of the LGL regulatory familyImmunology Today, 1986
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986
- Increase of Hybridoma Formation by Addition of Dextran Sulphate to In Vitro Immunization SystemHybridoma, 1986
- Monoclonal Antibodies to Digoxin: Comparison of In Vitro and In Vivo ImmunizationHybridoma, 1985
- Dependence on T-cell-replacing factor and immunogenic dose for the production of monoclonal antibodies using the in vitro immunization techniqueMolecular Immunology, 1984
- Monoclonal antibody to the hen oviduct progesterone receptor produced following in vitro immunizationJournal of Steroid Biochemistry, 1984
- In Vitro Immunization for the Production of Antigen-Specific Lymphocyte HybridomasScandinavian Journal of Immunology, 1983
- Production of monoclonal antibodies against calmodulin by in vitro immunization of spleen cells.The Journal of cell biology, 1983
- In Vitro Immunization of Mouse Spleen Cells and the Production of Monoclonal Antibodies.Acta Chemica Scandinavica, 1983
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974